Chronic News and Research

RSS

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis

Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.

14 Mar 2011

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB, has initiated a Phase IIb clinical study of its ChronVac-C DNA vaccine for hepatitis C virus, delivered by Inovio's proprietary electroporation DNA vaccine delivery technology, in combination with standard of care.

14 Mar 2011

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.

14 Mar 2011

New study identifies 15 genetic regions underlying primary biliary cirrhosis

Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients.

14 Mar 2011

New study: Alcohol-related chronic pancreatitis is lower than other causes

The relative rate of alcohol-related chronic pancreatitis is lower when compared to other causes, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.

14 Mar 2011

Novel biomarkers may aid in diagnosis and management of asthma, COPD

Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease, according to a study conducted by researchers in Australia, who determined the biomarkers may be used in different combinations to successfully identify patients with either of the airway diseases.

14 Mar 2011

Test that measures destruction of lung air sacs, could help prevent progression of emphysema

During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema -- well before symptoms occur -- may someday also be offered.

12 Mar 2011

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

11 Mar 2011

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.

11 Mar 2011

Canadian Partnership to receive second mandate from Harper Government for cancer control

Today's announcement of renewed support for cancer control by Prime Minister Harper is great news for Canadians. The Canadian Partnership Against Cancer is receiving a second five-year mandate, to begin in 2012, and $250 million in funding to continue implementation of Canada's national cancer control strategy.

11 Mar 2011

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Seventy per cent of men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg, according to a paper in the March issue of the urology journal BJUI.

11 Mar 2011

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Diabetes and high blood pressure are the two leading causes of chronic kidney disease, a health problem that is growing at an alarming rate in the United States. There are 26 million Americans who have CKD, and millions more are at increased risk and may not even know it.

11 Mar 2011

Researchers uncover new disease mechanism in patients with CGD

Infection researchers at Umeå University have uncovered a new disease mechanism in patients with Chronic Granulomatous Disease in an international clinical collaboration with the Children's Hospital in Zurich.

11 Mar 2011

Seattle Children's Hospital inaugurates new dialysis unit

Today, timed with World Kidney Day, Seattle Children's Hospital announced the opening of its newly renovated dialysis unit. The unit will significantly improve patient comfort and safety compared to its predecessor facility, and includes an additional 630 square feet of space for a total of nearly 2,400 square feet.

11 Mar 2011

Researchers create protein molecule for new anti-inflammatory therapies

Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.

11 Mar 2011

Depression is linked with increased risk of developing kidney failure

Depression is associated with an increased risk of developing kidney failure in the future, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

10 Mar 2011

Avinger completes patient enrollment in CONNECT trial to treat CTOs linked with PAD

Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.

10 Mar 2011

International panel revises, simplifies 'McDonald Criteria' for diagnosis of multiple sclerosis

International Panel Revises "McDonald Criteria" for Diagnosing MS -- Use of new data should speed diagnosis -- Publication coincides with MS Awareness Week

10 Mar 2011

FDA grants marketing clearance for Teleflex Arrow NextStep Antegrade Chronic Hemodialysis Catheter

Teleflex Incorporated, a global provider of medical technology products, announced today that its Arrow® NextStep™ Antegrade Chronic Hemodialysis Catheter has received market clearance from the U.S. Food and Drug Administration (FDA). The NextStep Antegrade Chronic Hemodialysis Catheter is designed to attain long-term vascular access for hemodialysis and apheresis.

10 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Chronic News and Research

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

New study identifies 15 genetic regions underlying primary biliary cirrhosis

New study: Alcohol-related chronic pancreatitis is lower than other causes

Novel biomarkers may aid in diagnosis and management of asthma, COPD

Test that measures destruction of lung air sacs, could help prevent progression of emphysema

Inhibitex fourth quarter net loss increases to $7.0 million

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Canadian Partnership to receive second mandate from Harper Government for cancer control

Majority of men on ADT after prostatectomy gain weight during first year of therapy

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Researchers uncover new disease mechanism in patients with CGD

Seattle Children's Hospital inaugurates new dialysis unit

Researchers create protein molecule for new anti-inflammatory therapies

Depression is linked with increased risk of developing kidney failure

Avinger completes patient enrollment in CONNECT trial to treat CTOs linked with PAD

International panel revises, simplifies 'McDonald Criteria' for diagnosis of multiple sclerosis

FDA grants marketing clearance for Teleflex Arrow NextStep Antegrade Chronic Hemodialysis Catheter

Idera reports $6.0 million net loss for fourth quarter 2010

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News